Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 26
2014 280
2015 444
2016 496
2017 554
2018 615
2019 279
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

2,308 results
Results by year
Filters applied: . Clear all
Page 1
Non-alcoholic fatty liver disease.
Neuschwander-Tetri BA. BMC Med 2017 - Review. PMID 28241825 Free PMC article.
Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies. ...This overview briefly summarizes the most recent data on the pathophysiology, diagnosis, and treatment of non-alcoholic fatty liver disease. ...
Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in
Non-Alcoholic Fatty Liver Disease.
Engin A. Adv Exp Med Biol 2017 - Review. PMID 28585211
Non-alcoholic fatty liver disease (NAFLD) is in parallel with the obesity epidemic and it is the most common cause of liver diseases. ...Insulin resistance is the major mechanism in the development and progression of NAFLD/Non-alcoholic steatohepatitis (NASH). Metabolic oxidative stress, autophagy, and inflammation induce NASH progression. ...
Non-alcoholic fatty liver disease (NAFLD) is in parallel with the obesity epidemic and it is the most com
Pathology of non-alcoholic fatty liver disease.
Bedossa P. Liver Int 2017 - Review. PMID 28052629
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of lesions ranging from steatosis (Non-alcoholic Fatty Liver or NAFL) to a complex pattern with hepatocellular injury and inflammation (non-alcoholic steatohepatitis; NASH) in the absence of alcohol intake. ...The histopathological evaluation of liver biopsy samples is central in the diagnosis of NAFLD and NASH in the absence of sufficiently accurate non-invasive tests because a precise definition of each group is a key issue. ...
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of lesions ranging from steatosis (Non
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.
Ipsen DH, et al. Cell Mol Life Sci 2018 - Review. PMID 29936596 Free PMC article.
Non-alcoholic fatty liver disease (NAFLD) is currently the world's most common liver disease, estimated to affect up to one-fourth of the population. ...Hepatic steatosis is a consequence of lipid acquisition exceeding lipid disposal, i.e., the uptake of fatty acids and de novo lipogenesis surpassing fatty acid oxidation and export. ...
Non-alcoholic fatty liver disease (NAFLD) is currently the world's most common liver disease
Non-alcoholic fatty liver disease and dyslipidemia: An update.
Katsiki N, et al. Metabolism 2016 - Review. PMID 27237577
Non-alcoholic fatty liver (NAFLD) is the most common liver disease worldwide, progressing from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic steatohepatitis, NASH), and in some cases to cirrhosis and hepatocellular carcinoma. ...Most importantly, NAFLD patients have an increased risk for both liver and CV disease (CVD) morbidity and mortality. In this narrative review, the associations between NAFLD, dyslipidemia and vascular disease in NAFLD patients are discussed. ...
Non-alcoholic fatty liver (NAFLD) is the most common liver disease worldwide, progressing from sim
Mechanisms of NAFLD development and therapeutic strategies
Friedman SL, et al. Nat Med 2018 - Review. PMID 29967350 Free PMC article.
There has been a rise in the prevalence of nonalcoholic fatty liver disease (NAFLD), paralleling a worldwide increase in diabetes and metabolic syndrome. NAFLD, a continuum of liver abnormalities from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), has a variable course but can lead to cirrhosis and liver cancer. ...
There has been a rise in the prevalence of nonalcoholic fatty liver disease (NAFLD), paralleling a worldwide increase i …
Non-alcoholic fatty liver disease and diabetes.
Hazlehurst JM, et al. Metabolism 2016 - Review. PMID 26856933 Free PMC article.
Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM) are common conditions that regularly co-exist and can act synergistically to drive adverse outcomes. ...Achieving good glycaemic control and optimising weight loss are pivotal to restricting disease progression. Once cirrhosis has developed, it is necessary to screen for complications and minimise the risk of hepatic decompensation. ...
Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM) are common conditions that regularly
Epidemiology and natural history of non-alcoholic fatty liver disease.
Fazel Y, et al. Metabolism 2016 - Review. PMID 26997539
Non-alcoholic steatohepatitis (NASH) is part of the spectrum of non-alcoholic fatty liver disease (NAFLD) that leads to progressive liver disease and presents a growing challenge to public health. ...Therefore, due to the lack of a reliable and accepted non-invasive diagnostic modality, screening for NASH in the general population is not currently recommended. ...
Non-alcoholic steatohepatitis (NASH) is part of the spectrum of non-alcoholic fatty liver disea
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
Papatheodoridi M and Cholongitas E. Curr Pharm Des 2018 - Review. PMID 30652642
Nonalcoholic fatty liver disease (NAFLD) ranges from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. ...To date, ultrasound is suggested as first-line screening tool for defining steatosis in a selected population, while diagnosis of NAFLD requires exclusion of other chronic liver disease etiology or other steatosis causes. ...
Nonalcoholic fatty liver disease (NAFLD) ranges from simple hepatic steatosis to non-alcoholic steatohepa …
Non-alcoholic fatty liver disease: A sign of systemic disease.
Reccia I, et al. Metabolism 2017 - Review. PMID 28641788 Free article.
Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and leading cause of cirrhosis in the United States and developed countries. ...In this review, we bring together the current understanding of the pathogenesis that makes NAFLD a systemic disease....
Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and lead
2,308 results
Jump to page
Feedback